SYNERGY: 1L chemo-immunotherapy with or without the anti-CD73 antibody oleclumab in advanced TNBC
Laurence Buisseret • 10 Sep 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter